Pneumonia during pregnancy: has modern technology improved maternal and fetal outcome
Article Abstract:
Pneumonia, a lung infection caused by bacteria and viruses, is an uncommon complication during pregnancy. Although the use of antibiotics for the treatment of bacterial infections has lowered the overall maternal death rate, the death rate and the rate of early delivery which can be attributed to this complication have remained unchanged. Women having a history of lung diseases and compromised immune systems as a result of infection, drug therapy and cancer are now having babies because of improved survival in the reproductive years. It has been suggested that the introduction of new organisms and the increase of women at risk for infections will affect the prevalence of pneumonia during pregnancy. Of the 32,179 pregnancies reviewed in this study, there were 25 cases of pneumonia during pregnancy. The complications that developed from the pneumonia included bacterial infections in the blood stream (16 percent), pus in the lung cavity (8 percent), abnormal heart beats (4 percent), and breathing failure requiring a respirator (20 percent). Labor and delivery complications included early labor (44 percent) and early delivery (36 percent). Women with an underlying disease were more likely to develop complications of pneumonia. The incidence of pneumonia during pregnancy is considered to be low; however, 40 percent of the cases reviewed from all sources developed complications as a result of the infectious disease.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1989
User Contributions:
Comment about this article or add new information about this topic:
The impact of fetal compromise on outcome at the border of viability
Article Abstract:
Premature infants who do not have any serious health problems may have a very good prognosis. Researchers studied survival rates in 142 babies born prematurely at 23 to 25 weeks. Forty-three infants had some type of health problem including birth defects, congenital infection, drug exposure, anemia, severe growth restriction or cardiorespiratory or neurologic disorders. The survival rate in these infants was 33%, compared to 75% in infants with no health problems. In infants born at 23 weeks, only 6% of those with health problems survived compared to 75% of those without health problems.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
The NICHD-MFMU antibiotic treatment of preterm PROM study: Impact of initial amniotic fluid volume on pregnancy outcome
Article Abstract:
A study to evaluate the association between measured amniotic fluid volume and outcome after preterm premature rupture of membranes (PROM) was conducted. Preterm PROM is responsible for approximately one third of preterm births whereas low residual amniotic fluid volume subsequent to membrane rupture, assessed by either single or multiple measurements was associated with early delivery as well as subsequent infectious morbidity.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Group B streptococci during pregnancy: a comparison of two screening and treatment protocols. Optimal dosing of penicillin G in the third trimester of pregnancy for prophylaxis against group B Streptococcus
- Abstracts: Thrombotic thrombocytopenic purpura in pregnancy with maternal and fetal survival: case report. Rubella infection in pregnancy: remaining problems
- Abstracts: Preterm labour in twin pregnancies: can it be prevented by hospital admission?
- Abstracts: The variability of young children's energy intake. Children and food - order amid chaos. Fast-food fare: consumer guidelines
- Abstracts: Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood. Inhibin as a marker for granulosa-cell tumors